{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:22:27Z","timestamp":1791850947168,"version":"4.3.4"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Cancer-related pain (CRP) is a common, most feared symptom experienced by cancer patients, adversely affecting quality of life and cancer outcomes. Patient-reported outcomes (PRO) measures are a patient's report of their health condition without interpretation of the response by a health care provider. This study assesses PRO measures after therapy using an intrathecal drug delivery system (IDDS) for cancer pain management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, subjects, and methods<\/jats:title>\n                    <jats:p>The retrospective study included adult patients undergoing IDDS implantation from January 2022 to January 2023 at the University of Minnesota Medical Center. Patients with moderate to severe CRP (VAS\u2009&amp;gt;\u20094) who had failed conventional medical therapy for pain control or had severe opioid-related side effects were considered for IDDS therapy. PRO measures were evaluated by the Patient Reported Outcomes Measurement Information System (PROMIS). The measurements were collected weekly during the first month after implantation and then during monthly follow-up. Linear mixed effects models with a random intercept for each participant are fit to the PROMIS outcomes to compare the change in scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the study period, 23 patients received IDDS treatment for CRP, and 20 patients (age 57.2\u2009\u00b1\u200917.1\u2009years, female sex 65%, Caucasian ethnicity 90%, stage IV cancer 90%) were included in the final analysis. The mean oral morphine equivalent consumption at implantation was 237\u2009\u00b1\u2009309. The patients started with severely reduced physical function, mobility, self-efficacy, social activity, social role, and satisfaction with roles. They also presented with mild-moderate sleep disturbance, anxiety, and depression symptoms. Of all the domains, pain interference and sleep disturbance consistently improved throughout the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pain interference and Sleep disturbance as measured by PRO measures improved with IDDS therapy among patients with refractory pain and advanced metastatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/pm\/pnaf012","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T10:10:20Z","timestamp":1743588620000},"page":"261-268","source":"Crossref","is-referenced-by-count":5,"title":["Cancer patients quality of life after intrathecal drug delivery for advanced pain management: a patient-reported outcome analysis"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-1399","authenticated-orcid":false,"given":"Vasudha","family":"Goel","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, University of Minnesota , Minneapolis, MN 55455,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kaizer","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus , Aurora, CO 80045,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Darrow","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Minnesota , Minneapolis, MN 55455,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Rosielle","sequence":"additional","affiliation":[{"name":"Department of Family and Community Health, University of Minnesota , Minneapolis, MN 55455,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Owens","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology Oncology Transplantation, University of Minnesota , Minneapolis, MN 55455,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-4810","authenticated-orcid":false,"given":"Anne","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"2025050203521094000_pnaf012-B1","year":"2022"},{"issue":"18","key":"2025050203521094000_pnaf012-B2","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1001\/jama.290.18.2476","article-title":"Cancer pain","volume":"290","author":"Bruera","year":"2003","journal-title":"JAMA"},{"issue":"9","key":"2025050203521094000_pnaf012-B3","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"issue":"2","key":"2025050203521094000_pnaf012-B4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0304-3959(94)00178-H","article-title":"When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function","volume":"61","author":"Serlin","year":"1995","journal-title":"Pain"},{"key":"2025050203521094000_pnaf012-B5","author":"WHO","year":"1986"},{"issue":"2","key":"2025050203521094000_pnaf012-B6","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"2025050203521094000_pnaf012-B7","first-page":"514","article-title":"Is the WHO analgesic ladder still valid? Twenty-four years of experience","volume":"56","author":"Vargas-Schaffer","year":"2010","journal-title":"Can Fam Physician"},{"issue":"3","key":"2025050203521094000_pnaf012-B8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0304-3959(01)00324-4","article-title":"Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology","volume":"93","author":"Meuser","year":"2001","journal-title":"Pain"},{"issue":"19","key":"2025050203521094000_pnaf012-B9","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival","volume":"20","author":"Smith","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"2025050203521094000_pnaf012-B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"2025050203521094000_pnaf012-B11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/ner.12538","article-title":"The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best practices and guidelines","volume":"20","author":"Deer","year":"2017","journal-title":"Neuromodulation"},{"key":"2025050203521094000_pnaf012-B12","author":"US Department of Health and Human Services Food and Drug Administration"},{"issue":"2","key":"2025050203521094000_pnaf012-B13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s13187-016-0997-2","article-title":"Who is a cancer survivor? A systematic review of published definitions","volume":"32","author":"Marzorati","year":"2017","journal-title":"J Cancer Educ"},{"issue":"6","key":"2025050203521094000_pnaf012-B14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0885-3924(96)00010-3","article-title":"Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines","volume":"11","author":"Krames","year":"1996","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"2025050203521094000_pnaf012-B15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ner.13517","article-title":"Initial intrathecal dose titration and predictors of early dose escalation in patients with cancer using a 100:1 oral to intrathecal morphine conversion ratio","volume":"24","author":"Sindt","year":"2021","journal-title":"Neuromodulation"},{"key":"2025050203521094000_pnaf012-B16"},{"issue":"11","key":"2025050203521094000_pnaf012-B17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"17","key":"2025050203521094000_pnaf012-B18","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1200\/JCO.2016.71.4410","article-title":"United States population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer","volume":"35","author":"Jensen","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"2025050203521094000_pnaf012-B19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1213\/ANE.0000000000004425","article-title":"Intrathecal drug delivery systems for cancer pain: an analysis of a prospective, multicenter product surveillance registry","volume":"130","author":"Stearns","year":"2020","journal-title":"Anesth Analg"},{"issue":"5","key":"2025050203521094000_pnaf012-B20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/annonc\/mdi156","article-title":"An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)","volume":"16","author":"Smith","year":"2005","journal-title":"Ann Oncol"},{"issue":"4","key":"2025050203521094000_pnaf012-B21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/AAP.0000000000000251","article-title":"Prospective observational study of patient-controlled intrathecal analgesia: impact on cancer-associated symptoms, breakthrough pain control, and patient satisfaction","volume":"40","author":"Brogan","year":"2015","journal-title":"Reg Anesth Pain Med"},{"issue":"7","key":"2025050203521094000_pnaf012-B22","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ner.12759","article-title":"Retrospective analysis of intrathecal drug delivery: outcomes, efficacy, and risk for cancer-related pain at a high volume academic medical center","volume":"21","author":"Sayed","year":"2018","journal-title":"Neuromodulation"},{"issue":"4","key":"2025050203521094000_pnaf012-B23","doi-asserted-by":"publisher","first-page":"e191549","DOI":"10.1001\/jamanetworkopen.2019.1549","article-title":"Assessment of health care utilization and cost of targeted drug delivery and conventional medical management vs conventional medical management alone for patients with cancer-related pain","volume":"2","author":"Stearns","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2025050203521094000_pnaf012-B24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/ner.13175","article-title":"Initiation of intrathecal drug delivery dramatically reduces systemic opioid use in patients with advanced cancer","volume":"23","author":"Sindt","year":"2020","journal-title":"Neuromodulation"},{"issue":"9","key":"2025050203521094000_pnaf012-B25","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/pon.2004","article-title":"Sleep problems in cancer patients: prevalence and association with distress and pain","volume":"21","author":"Sharma","year":"2012","journal-title":"Psychooncology"},{"issue":"2","key":"2025050203521094000_pnaf012-B26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1087-0792(03)00044-3","article-title":"How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature","volume":"8","author":"Smith","year":"2004","journal-title":"Sleep Med Rev"},{"issue":"5","key":"2025050203521094000_pnaf012-B27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1177\/1049909117739299","article-title":"Sleep disturbance mediates the association of post-traumatic stress disorder symptoms and pain in patients with cancer","volume":"35","author":"Lillis","year":"2018","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"2025050203521094000_pnaf012-B28","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/j.pain.0000000000000881","article-title":"Pain interference and physical function demonstrate poor longitudinal association in people living with pain: a PROMIS investigation","volume":"158","author":"Karayannis","year":"2017","journal-title":"PAIN"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnaf012\/62858108\/pnaf012.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/26\/5\/261\/62858108\/pnaf012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/26\/5\/261\/62858108\/pnaf012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T03:52:20Z","timestamp":1746157940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/26\/5\/261\/8105766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,4,4]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnaf012","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"value":"1526-2375","type":"print"},{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,4]]}}}